Paper36938103
Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.
Ackun-Farmmer MA and 1 other. Adv Nanobiomed Res, 2023. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity. Papers, record 36938103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36938103
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| I01 BX003690 | BLRD VA | United States | I01BX003690 | PubMed and NIH | NIH RePORTER |
| R01 AI144667 | NIAID NIH HHS | United States | R01AI144667 | PubMed and NIH | NIH RePORTER |
| R01 AI169686 | NIAID NIH HHS | United States | R01AI169686 | PubMed and NIH | NIH RePORTER |
| R01 EB027143 | NIBIB NIH HHS | United States | R01EB027143 | PubMed and NIH | NIH RePORTER |
References144
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21975206 | A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS. | Neurology | 2011 | https://conductscience.org/library/papers/21975206 | PubMed |
| 2 | 7680493 | Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. | Science | 1993 | https://conductscience.org/library/papers/7680493 | PubMed |
| 3 | 26509048 | Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response. | RMD Open | 2015 | https://conductscience.org/library/papers/26509048 | PubMed |
| 4 | 28772190 | An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis. | Biomaterials | 2017 | https://conductscience.org/library/papers/28772190 | PubMed |
| 5 | 28116870 | Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation. | Adv Healthc Mater | 2017 | https://conductscience.org/library/papers/28116870 | PubMed |
| 6 | 24430972 | Intra-lymph node injection of biodegradable polymer particles. | J Vis Exp | 2014 | https://conductscience.org/library/papers/24430972 | PubMed |
| 7 | 34668580 | Tolerance induction by liposomes targeting a single CD8 epitope IGRP206-214 in a model of type 1 diabetes is impeded by co-targeting a CD4+ islet epitope. | Immunol Cell Biol | 2022 | https://conductscience.org/library/papers/34668580 | PubMed |
| 8 | 35359943 | Mapping the Mechanical and Immunological Profiles of Polymeric Microneedles to Enable Vaccine and Immunotherapy Applications. | Front Immunol | 2022 | https://conductscience.org/library/papers/35359943 | PubMed |
| 9 | 28199812 | Intralymphatic Injection of Autoantigen in Type 1 Diabetes. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28199812 | PubMed |
| 10 | 18688037 | Sex differences in autoimmune disease from a pathological perspective. | Am J Pathol | 2008 | https://conductscience.org/library/papers/18688037 | PubMed |
| 11 | 33881872 | Biophysical Properties of Self-Assembled Immune Signals Impact Signal Processing and the Nature of Regulatory Immune Function. | Nano Lett | 2021 | https://conductscience.org/library/papers/33881872 | PubMed |
| 12 | 35679343 | Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35679343 | PubMed |
| 13 | 9395124 | Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis. | J Neurol Sci | 1997 | https://conductscience.org/library/papers/9395124 | PubMed |
| 14 | 33144616 | Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes. | Sci Rep | 2020 | https://conductscience.org/library/papers/33144616 | PubMed |
| 15 | 11079539 | NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients. | Ann Neurol | 2000 | https://conductscience.org/library/papers/11079539 | PubMed |
| 16 | 26348965 | Principles of nanoparticle design for overcoming biological barriers to drug delivery. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/26348965 | PubMed |
| 17 | 29148731 | Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide- co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance. | Bioconjug Chem | 2018 | https://conductscience.org/library/papers/29148731 | PubMed |
| 18 | 32209459 | Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity. | Cell Rep | 2020 | https://conductscience.org/library/papers/32209459 | PubMed |
| 19 | 31119191 | Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model. | ACS Biomater Sci Eng | 2019 | https://conductscience.org/library/papers/31119191 | PubMed |
| 20 | 33645967 | Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy. | ACS Nano | 2021 | https://conductscience.org/library/papers/33645967 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42922362 | Physicochemical design principles for B cell targeted acetalated dextran microparticles in antigen-specific tolerance for multiple sclerosis. | Biomater Sci | 2026 | https://conductscience.org/library/papers/42922362 | PubMed |
| 42194053 | Plant-Derived Nanovesicles: A Comprehensive Review from Isolation to Clinical Translation-Unlocking Natural Nanocarriers for Biomedical Applications. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194053 | PubMed |
| 41321036 | Antigen-Specific Inverse Vaccination Strategies Using Particle Systems for Multiple Sclerosis. | ACS Biomater Sci Eng | 2026 | https://conductscience.org/library/papers/41321036 | PubMed |
| 41316372 | Reprogramming autoimmunity: inducing antigen-specific tolerance via apoptotic mimicry in an experimental model of multiple sclerosis. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/41316372 | PubMed |
| 41280059 | Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis. | bioRxiv | 2025 | https://conductscience.org/library/papers/41280059 | PubMed |
| 41183200 | Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41183200 | PubMed |
| 41183192 | Structural immunotherapy: Harnessing chemical design to build powerful next-generation therapeutics. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41183192 | PubMed |
| 41172992 | Defined distribution and features of lymph node therapies enable recruitment and manipulation of antigen-specific T cell response. | Mol Ther | 2026 | https://conductscience.org/library/papers/41172992 | PubMed |
| 40182604 | From Edmonton to Lantidra and beyond: immunoengineering islet transplantation to cure type 1 diabetes. | Front Transplant | 2025 | https://conductscience.org/library/papers/40182604 | PubMed |
| 39520377 | Engineered Immune Constructs Alter Antigen-Specific Immune Tolerance and Confer Durable Protection in Myelin-Driven Autoimmunity. | ACS Nano | 2024 | https://conductscience.org/library/papers/39520377 | PubMed |
| 38670230 | Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38670230 | PubMed |
| 38342243 | Emerging strategies for nanomedicine in autoimmunity. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38342243 | PubMed |
| 38166244 | Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation. | J Immunol | 2024 | https://conductscience.org/library/papers/38166244 | PubMed |
| 37935318 | Engineering metabolism to modulate immunity. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/37935318 | PubMed |
| 37877041 | Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37877041 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36938103
GET https://conductscience.org/api/papers/v1/36938103/references?page=2